August 31, 2019

Glycanostics succesfully finished Horizon 2020 SME Instrument 1 Grant

In august 2019, Glycanostics successfully finished the first phase of SME Instrument, by finishing a feasibility study and a business plan with the help from advisors and a consultation agency. Further information are in the Publishable summary, which can be downloaded from this link.

Other News

October 18, 2019

A highly-prestigious award for a Glycanostics co-founder

ESET launched a prestigious ESET Science Award for exceptional scientists

READ MORE
October 3, 2019

International Patent Application No. PCT/EP2019/057386

Means and methods for glycoprofiling of a protein

READ MORE
December 10, 2018

Glycanostics Wins Horizon 2020 Grant

After receiving the prestigious “Seal of Excellence” on October 23, the next submission to the Horizon 2020 Programme, won a € 50 000 grant.

READ MORE
October 27, 2018

Glycanostics Receives the Prestigious Horizon 2020 “Seal of Excellence”

This project received the highest scores for its proposal in the extremely competitive evaluation process.

READ MORE
October 24, 2018

Glycanostics Wins TOP-6 Best Startups in Central Europe

Glycanostics was chosen as a finalist in the Grand Finale with five other remarkable startups.

READ MORE
August 14, 2018

Glycanostics Applies for Innovation-Securing Patent

The application covering Glycanostics' diagnostic method is currently filed in two patent offices in Europe and Luxemburg.

READ MORE
July 27, 2018

Glycanostics wins the European Research Council Grant

Glycanoctics innovations are again supported and highly ranked by leading industry experts. This time the company won the European Research Council (ERC) Proof of Concept Grant.

READ MORE
June 14, 2018

Glycanostics Takes 3rd Place in Vodafone’s Idea of The Year Competition

The competition's objectives are to actively support innovative projects with high market potential

READ MORE
May 1, 2018

Glycanostics PCa DX kit showed 95+% accuracy on the pre-clinical validation

In April 2018 the technology validation was successfully completed indicating a great potential of Glycanostics innovative products for prostate cancer (PCa) diagnostics.

READ MORE
November 30, 2017

Jan Tkac and Tomas Bertok – Scientists of the year award winners - establish Glycanostics to bring their revolutionary innovation to cancer diagnostics market

Glycanostics is an innovative start-up company established in 2017 to bring its revolutionary cancer diagnostics products to the US and EU markets.

READ MORE